Finance Watch: A Plethora Of Venture Capital Mega-Rounds To Kick Off Q4

Q3 Ended With $205m For Crystalys, $125m For Star

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.